Nucleic Acid Testing Market to Reach USD 4.70 Billion by 2028 – Reports and Data

Rising prevalence of chronic, infectious diseases, and increasing research & development activities to promote nucleic acid testing

The global nucleic acid testing market to reach USD 4.70 billion by 2028 at a CAGR of 7.2%, according to the latest report by Reports and Data. Major factors responsible for market revenue growth are rising prevalence of infectious diseases, cancers, etc., advancement in healthcare infrastructure, increasing awareness of nucleic acid testing methods for screening pathogenic bacteria, viruses in patient’s blood, tissue and urine. Increasing research & development activities in the field for innovating diagnosis procedures, is further expected to drive market revenue growth over the forecast period.

Nucleic acid testing (NAT) is a molecular technique for diagnosing viruses, bacteria. It is an advanced technique to detect the presence of infectious elements in blood, urine, etc. These testing methods are useful in identification of genetic disorders in early stage even if there are no visible symptoms. Nucleic acid testing methods are beneficial due to their rapid screening, accuracy, and efficiency. Increasing government spending on healthcare infrastructure is one of the key factors expected to boost market revenue growth over the forecast period. There are lucrative opportunities for the market contributors operating in the global nucleic acid testing market. The increasing number of cancer patients across the globe, and rising awareness of early detection of such disorders to avoid major complications, are some key factors expected to contribute to market growth going ahead.

However, high costs, lack of skilled professionals, and safety issues are the factors expected to hamper nucleic acid testing market growth to a certain extent over the forecast period.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1429  

Some Key Highlights from the Report:

• Among the product type segment, Polymerase Chain Reaction (PCR) is expected to account for a largest revenue share in the global market due to its low cost and diverse applicability in DNA typing, cloning, disease detection, etc.
• In the technique segment, the target amplification systems is expected to register significant revenue share in the global market. This is because of its high efficiency, simplicity, and productivity.
• Infectious diseases are expected to register largest revenue share in the global market in the application segment due to applicability of nucleic acid testing methods in diagnosis of various infectious diseases.
• Hospitals segment is expected to register robust revenue in the global market over the forecast period. Improvement in healthcare infrastructure, technological advancement, and rising prevalence of infectious diseases.
• Asia Pacific market revenue is expected to expand significantly over the forecast period due to rising prevalence of cancer, and infectious diseases, better healthcare facilities, advanced diagnosis methods, and growing health awareness. In addition, ongoing research & development in biotechnology, is the factor responsible for the market growth.
• Key companies in the nucleic acid testing market include Applied Genetic Technologies Corporation, Abbott, Affymetrix, Becton, Dickinson and Company, Illumina, Inc., Bio-Rad, Diadexus, ELITech Group, Exact Sciences, Leica Biosystems, Perkin Elmer, and Siemens Healthineers, among others.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1429

For the purpose of this report, Reports and Data has segmented the global nucleic acid testing market has been segmented into product type, technique, application, end-user, and region:

Product Type Outlook (Revenue, USD Billion; 2018 – 2028)

• Ligase Chain Reaction
• Polymerase Chain Reaction (PCR)
• Transcription-mediated Amplification (TMA)
• Consumables
• Whole Genome Sequencing

Technique Outlook (Revenue, USD Billion; 2018 – 2028)

• Probe Amplification Systems
• Target Amplification Systems
• Signal Amplification

Application Outlook (Revenue, USD Billion; 2018 – 2028)

• Infectious Diseases

• Viral Detection & Load
• Viral & Bacterial Genotyping
• Bacterial Tests

• Genetic And Mitochondrial Disorders

• Disease Predisposition
• Generic Testing

• Cancer

• Chromosomal Aberrations
• Cervical Cancer Screening
• Breast Cancer

• Forensic Testing
• Paternity Testing/Hla Typing
• Personalized Medicine

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1429

End-User Outlook (Revenue, USD Billion; 2018 – 2028)

• Government-Regulated Clinical Laboratories
• Hospitals
• Clinics
• Academic And Research Institutions Dermatology
• R&D Centers

Region Outlook (Revenue, USD Billion; 2018 – 2028)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Allergy Diagnostic Assay Kits Market Growth, Trends & Analysis, By Product Type (Allergen Screening, Allergen Classification Test), By Application (Inhaled Allergens Assay, Food Allergens Assay), By End-Use (Diagnostics Laboratories, Hospital-Based Laboratories, Academic & Research Institutes, Others), And Region, Forecast To 2027

Helicobacter Pylori Diagnostics Market Size, Trends & Analysis, By Technology (Immunoassays, POC, Molecular Diagnostics), By End-User (Hospitals, Diagnostics Laboratories, Clinics), And Regional Forecasts To 2027

Diagnostic Reagent Market Size, Trends & Analysis By Type (Clinical Reagents, Analytical Reagents, Others), By Application (Hospitals, Laboratories, Research Institutions), By Region, Segment Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-nucleic-acid-testing-market